Abstract

BackgroundRenal cell carcinomas (RCC) are characterized by the deregulation of several hundred hyperosmolality-responsive genes. High expression of a subset of these genes including the Ran binding protein 3 like (RANBP3L) is linked to a favorable prognostic outcome in RCC. However, the cellular function of RANBP3L remains largely unknown.MethodsWe used CRISPR/Cas9-mediated gene editing to generate functional deletions of the Ranbp3l and nuclear factor of activated T cells 5 (Nfat5) gene loci in a murine renal cell line. The NFAT5-KO cells were used to assess the regulation of Ranbp3l by NFAT5 using immunofluorescence, RNA-Seq and promoter assays. RANBP3L-deficient cells were analyzed for changes in cell morphology, proliferation, migration and colony-forming capacity using immunofluorescence and live cell imaging. RANPB3L-dependent changes in gene expression were identified by RNA-Seq.ResultsWe show that NFAT5 directly regulates Ranpb3l under hyperosmotic conditions by binding its promoter. Functional analysis of RANBP3L-deficient cells revealed a loss of epithelial structure, an increased cell migration behavior and colony forming capacity, accompanied by massive alterations in gene expression, all of which are hallmarks for tumor cells. Strikingly, a RANBP3L dependent signature of 60 genes separated samples with clear cell carcinoma (KIRC) from papillary (KIRP), chromophobe renal carcinoma (KICH) and healthy tissue.ConclusionsLoss of RANBP3L induces a tumor like phenotype resembles RCC, especially KIRC, on the morphological and gene expression level and might promote tumor development and progression. Therapeutic reconstitution or elevation of osmoregulated RANBP3L expression might represent a novel treatment strategy for RCC or KIRC.

Highlights

  • Renal cell carcinomas (RCC) are characterized by the deregulation of several hundred hyperosmolality-responsive genes

  • We show that the expression of Ran binding protein 3-like (Ranbp3l) is induced by nuclear factor of activated T-cells 5 (NFAT5) under hyperosmotic conditions and that the loss of Ran binding protein 3 like (RANBP3L) induces the transformation towards a renal cancer cell like phenotype, especially KIRC

  • Hyperosmolality-induced Ranbp3l expression is triggered by NFAT5 RANBP3L belongs to the family of Ran binding proteins and shows a high similarity to RANBP3 (63%, TabS. 1 A, Fig. 1A)

Read more

Summary

Introduction

Renal cell carcinomas (RCC) are characterized by the deregulation of several hundred hyperosmolality-responsive genes. High expression of a subset of these genes including the Ran binding protein 3 like (RANBP3L) is linked to a favorable prognostic outcome in RCC. One major risk factor for developing RCC includes loss or inactivation of the von Hippel–Lindau (VHL) tumor suppressor gene [2]. The key transcription factor for inducing the primary cellular (hyper) osmoregulatory program is the nuclear factor of activated T-cells 5 (NFAT5; known as tonicity enhancer binding protein, TonEBP) [6, 7]. A recent example for this association is the microRNAmediated decrease of NFAT5 transcript levels in Caki-2 cells resulting in the downregulation of osmoprotective NFAT5 target genes, a pattern observed in clinical KIRC specimen [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call